A study of Total metabolic tumor volume in patients with relapsed/refractory diffuse large B cell lymphoma treated with CAR-T cells (Axicabtagene or Tisagenlecleucel)
Latest Information Update: 21 Jul 2020
At a glance
- Drugs Axicabtagene ciloleucel (Primary) ; Tisagenlecleucel (Primary)
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma
- Focus Therapeutic Use
- 21 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association